Evidence map›Paper›PMID 32885095›Full record

ArticleAmerican journal of ophthalmology case reports2020

Long-term follow-up of a case of amyloidosis-associated chorioretinopathy.

Koichi Nagura, Tatsuya Inoue, Jared Ching, Akinori Sato, Shohei Kitahata, Maiko Maruyama-Inoue, Masaru Takeuchi, Kazuaki Kadonosono

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Koichi NaguraDepartment of Ophthalmology and Micro-Technology, Yokohama City University, Kanagawa, Japan.
Tatsuya InoueDepartment of Ophthalmology and Micro-Technology, Yokohama City University, Kanagawa, Japan.
Jared ChingDepartment of Ophthalmology, Addenbrookes Hospital, Cambridge, UK.
Akinori SatoDepartment of Ophthalmology and Micro-Technology, Yokohama City University, Kanagawa, Japan.
Shohei KitahataDepartment of Ophthalmology and Micro-Technology, Yokohama City University, Kanagawa, Japan.
Maiko Maruyama-InoueDepartment of Ophthalmology and Micro-Technology, Yokohama City University, Kanagawa, Japan.
Masaru TakeuchiDepartment of Ophthalmology, National Defense Medical College, Saitama, Japan.
Kazuaki KadonosonoDepartment of Ophthalmology and Micro-Technology, Yokohama City University, Kanagawa, Japan.
Yokohama City University · JPNational Defense Medical College · JPAddenbrooke's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe the findings of long-term follow-up of a case of amyloidosis-associated chorioretinopathy by multimodal imagings, including optical coherence tomography (OCT). OBSERVATIONS: A 47-year-old woman who had been diagnosed as having systemic amyloidosis was found to have a best corrected visual acuity of 20/13 in both eyes at the age of 41, which subsequently decreased to 20/100 in the left eye and 20/20 in the right eye at age 47. Visual field examination demonstrated worsening of the central scotoma during the follow-up period. Funduscopic examination revealed bilateral white deposits along the choroidal vessels, which became more pronounced over time, along with diffuse pigmentary changes. The fluorescein angiography and indocyanine green angiography findings were consistent not only with atrophic lesions, but also with amyloid deposition (i.e., staining of the vessels).At the baseline, macula OCT revealed a thick hyporeflective band at the choriocapillaris, however, at the last follow-up, it revealed an absent ellipsoid zone, and bilateral progressive retinal pigment epithelium irregularities in both eyes.

conclusionsPatients diagnosed as having amyloidosis-related chorioretinopathy may have maintained visual function at the first detection of retinal amyloid deposition, and a number of years may elapse before the patient manifests visual deterioration.

Indexed as

AmyloidosisChorioretinopathy

Identifiers

PMID32885095
PMCPMC7453112
OpenAlexW3046306453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.